Wolverine Trading, LLC Aldeyra Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.19 - $6.32 $83,259 - $164,952
26,100 New
26,100 $140,000
Q1 2022

May 16, 2022
SELL
$3.25 - $5.17 $7,475 - $11,891
-2,300 Reduced 10.36%
19,900 $90,000
Q4 2021

Feb 14, 2022
BUY
$3.5 - $9.63 $16,100 - $44,298
4,600 Added 26.14%
22,200 $90,000
Q3 2021

Nov 12, 2021
BUY
$7.94 - $11.31 $139,744 - $199,056
17,600 New
17,600 $157,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email